Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jan 21;4(4):568–581. doi: 10.1158/1940-6207.CAPR-10-0140

Figure 2.

Figure 2

Terminal Body, Fat Pad Weights and Leptin, Adiponectin Serum Levels and Ratio of Adiponectin:Leptin of MMTV-TGF-α Female Mice. A. Final Body and Fat Pad Weights of MMTV-TGF-α Female Mice. Aa, Ab and Ac, AL (n=69), CCR (n=66), ICR-Refed (n=29) and ICR-Restricted (n=30) mice. Aa. Terminal Body Weight. ANOVA P<0.05. Ab. Mammary Fad Pad Weight (combined right and left mammary fat pads. ANOVA P<0.05. Ac. Internal Fat Pad Weight (combined parametrial and retroperitoneal fat pads). ANOVA P< 0.05. B. Terminal Leptin and Adiponectin Serum Level and Ratio of Adiponectin:Leptin of TGF-α Female Mice. Ba, Bb and Bc, AL (n=26), CCR (n=23), ICR-Refed (n=15–16) and ICR-Restricted (n=15) mice. Ba. Terminal Leptin serum levels. ANOVA P<0.05. Bb. Terminal Adiponectin serum levels. ANOVA P>0.05. Bc. Terminal Adiponectin:Leptin Ratio. ANOVA P<0.01. Ca. Terminal Leptin serum levels for mice with and without mammary tumors. t-test P>0.05. Cb. Terminal Adiponectin serum levels for mice with and without mammary tumors. t-test P>0.05. Cc. Terminal Adiponectin:Leptin Ratio for mice with and without mammary tumors. t-test P=0.03. Ca, Cb, Cc AL without mammary tumors (n=13), AL with mammary tumors (n=13). CCR without mammary tumors (n=7), CCR with mammary tumors (n=16). ICR-Refed without mammary tumors (n=13), ICR-Refed with mammary tumors (n=2). ICR-Rest without mammary tumors (n=12), ICR-Rest with mammary tumors (n=3). In A (a, b, c), B (a, b, c) and C (a, b, c) ICR-Refed mice were euthanized during a refeeding period and ICR-Restricted mice were euthanized during a restriction period. *, †, ‡ Columns with different superscripts are significantly different from each other.